Clinical Trials Directory

Trials / Sponsors / Windtree Therapeutics

Windtree Therapeutics

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Cardiogenic Shock
Phase 1 / Phase 22024-06-01
CompletedThe Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (CO
COVID-19, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Phase 22021-01-05
CompletedThe Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
Cardiogenic Shock
Phase 22020-09-28
TerminatedA Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
Respiratory Distress Syndrome, Newborn
Phase 22020-04-18
CompletedAntihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan
Hypertension
Phase 22015-12-01
CompletedThe Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
Respiratory Distress Syndrome
Phase 22015-12-01
CompletedThe Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
Acute Decompensated Heart Failure
Phase 22015-12-01
TerminatedTrial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks P
Respiratory Distress Syndrome
Phase 22015-08-01
CompletedTrial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates
Respiratory Distress Syndrome
Phase 22014-02-01
CompletedLucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
Acute Hypoxemic Respiratory Failure
Phase 22007-06-01
TerminatedSURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants
Respiratory Distress Syndrome, Newborn, Premature Birth, Bronchopulmonary Dysplasia
Phase 22005-02-01
TerminatedFeasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Prematur
Respiratory Distress Syndrome
Phase 22005-01-01
TerminatedKL₄Surfactant Treatment in Patients With ARDS
Acute Respiratory Distress Syndrome
Phase 22001-05-01
TerminatedPhase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Meconium Aspiration
Phase 32000-03-01